Skip to main content
News

Qiagen Acquires Enzymatics, Inks Partnership with ArcherDX – GenomeWeb

By January 12, 2015No Comments
Qiagen

Qiagen

Qiagen announced on Sunday that it has acquired the enzyme solutions unit of Enzymatics, a supplier of enzymes used in next-generation sequencing and other genetic analysis technologies in life sciences research and clinical applications, for an undisclosed amount.

{iframe}https://www.genomeweb.com/sequencing-technology/qiagen-acquires-enzymatics-inks-partnership-archerdx{/iframe}

Leave a Reply

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

BioHealth Innovation will use the information you provide on this form to be in touch with you and to provide updates and marketing.